About the Authors
- Xin Chen
-
Affiliation Department of Pathology and Laboratory Medicine, University of California Irvine, Irvine, California, United States of America
- Shizhong Xu
-
Affiliation Department of Genetics and Geneticist Botany and Plant Sciences, University of California Riverside, Riverside, California, United States of America
- Michael McClelland
-
Affiliations Department of Pathology and Laboratory Medicine, University of California Irvine, Irvine, California, United States of America, Vaccine Research Institute of San Diego, San Diego, California, United States of America
- Farah Rahmatpanah
-
Affiliation Department of Pathology and Laboratory Medicine, University of California Irvine, Irvine, California, United States of America
- Anne Sawyers
-
Affiliation Department of Pathology and Laboratory Medicine, University of California Irvine, Irvine, California, United States of America
- Zhenyu Jia
-
* E-mail: zjia@uci.edu (ZJ); dmercola@uci.edu (DM)
Affiliation Department of Pathology and Laboratory Medicine, University of California Irvine, Irvine, California, United States of America
- Dan Mercola
-
* E-mail: zjia@uci.edu (ZJ); dmercola@uci.edu (DM)
Affiliation Department of Pathology and Laboratory Medicine, University of California Irvine, Irvine, California, United States of America
Competing Interests
D. Mercola and M. McClelland are board members of Proveri Inc. which has a license from the Regents of the University of California for the development of clinical assays for prostate cancer. The other authors declare they have no conflict of interest with this publication. This does not alter the authors’ adherence to all of PLOS ONE’s policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: XC ZJ DM. Performed the experiments: XC AS ZJ. Analyzed the data: XC SX ZJ FR. Wrote the paper: XC ZJ MM DM.